Tunica albuginea allograft: a new model of LaPeyronie's disease with penile curvature and subtunical ossification

The pathophysiology of LaPeyronie's disease (PD) is considered to be multifactorial, involving genetic predisposition, trauma, inflammation and altered wound healing. However, these factors have not yet been validated using animal models. In this study, we have presented a new model obtained by tunica albuginea allograft. A total of 40, 16-week-old male rats were used. Of these, 8 rats served as controls and underwent a 10 × 2-mm-wide tunical excision with subsequent autografting, whereas the remaining 32 underwent the same excision with grafting of the defect with another rat's tunica. Morphological and functional testing was performed at 1, 3, 7 and 12 weeks after grafting. Intracavernous pressure, the degree of penile curvature and elastic fiber length were evaluated for comparison between the allograft and control groups. The tissues were obtained for histological examination. The penile curvature was significantly greater in the allografted rats as compared with the control rats. The erectile function was maintained in all rats, except in those assessed at 12 weeks. The elastin fiber length was decreased in the allografted tunica as compared to control. SMAD2 expression was detected in the inner part of the allograft, and both collagen-II- and osteocalcin-positive cells were also noted. Tunica albuginea (TA) allograft in rats is an excellent model of PD. The persistence of curvature beyond 12 weeks and the presence of ossification in the inner layer of the TA were similar to those observed in men with PD. Validation studies using this animal model would aid understanding of the PD pathophysiology for effective therapeutic interventions.

[1]  H. Akiyama,et al.  Notch signaling in chondrocytes modulates endochondral ossification and osteoarthritis development , 2013, Proceedings of the National Academy of Sciences.

[2]  G. Lin,et al.  Pentoxifylline promotes recovery of erectile function in a rat model of postprostatectomy erectile dysfunction. , 2011, European urology.

[3]  Eric Chung,et al.  Five-year follow-up of Peyronie's graft surgery: outcomes and patient satisfaction. , 2011, The journal of sexual medicine.

[4]  G. Brock,et al.  Rat as an animal model for Peyronie's disease research: a review of current methods and the peer-reviewed literature , 2011, International Journal of Impotence Research.

[5]  N. Gonzalez-Cadavid Mechanisms of penile fibrosis. , 2009, The journal of sexual medicine.

[6]  A. Bottaro,et al.  Susceptibility to autoimmunity and B cell resistance to apoptosis in mice lacking androgen receptor in B cells. , 2009, Molecular endocrinology.

[7]  T. Lue,et al.  Peyronie’s disease: Past, present, future? , 2008, Current urology reports.

[8]  J. Catania,et al.  Impact of Peyronie's disease on sexual and psychosocial functioning: qualitative findings in patients and controls. , 2008, The journal of sexual medicine.

[9]  S. Park,et al.  Repeated intratunical injection of adenovirus expressing transforming growth factor-beta1 in a rat induces penile curvature with tunical fibrotic plaque: a useful model for the study of Peyronie's disease. , 2008, International journal of andrology.

[10]  N. Longo,et al.  A new mouse model of Peyronie's disease: an increased expression of hypoxia-inducible factor-1 target genes during the development of penile changes. , 2008, The international journal of biochemistry & cell biology.

[11]  A. Bella,et al.  Continuing Medical Education: Peyronie's Disease (CME) , 2007 .

[12]  A. Bella,et al.  Peyronie's disease (CME). , 2007, The journal of sexual medicine.

[13]  T. Diemer,et al.  A critical analysis of nonsurgical treatment of Peyronie's disease. , 2006, European urology.

[14]  J. Marinković,et al.  Risk factors for Peyronie's disease: a case‐control study , 2006, BJU international.

[15]  J. Rajfer,et al.  Evidence That Osteogenic Progenitor Cells in the Human Tunica Albuginea May Originate from Stem Cells: Implications for Peyronie Disease1 , 2005, Biology of reproduction.

[16]  J. Rajfer,et al.  Gene Transfer of Inducible Nitric Oxide Synthase Complementary DNA Regresses the Fibrotic Plaque in an Animal Model of Peyronie's Disease1 , 2004, Biology of reproduction.

[17]  A. Qian,et al.  Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture. , 2004, Urology.

[18]  J. Zargooshi Trauma as the cause of Peyronie's disease: penile fracture as a model of trauma. , 2004, The Journal of urology.

[19]  Stephen A Boorjian,et al.  Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. , 2004, The Journal of urology.

[20]  T. Shankey,et al.  Chromosomal instability is demonstrated by fibroblasts derived from the tunica of men with Peyronie's disease , 2004, International Journal of Impotence Research.

[21]  S. Minhas,et al.  The management of Peyronie's disease , 2004, BJU international.

[22]  H. Hackstein,et al.  Prospective analysis of HLA classes I and II antigen frequency in patients with Peyronie's disease. , 2003, The Journal of urology.

[23]  J. Mulhall Expanding the paradigm for plaque development in Peyronie's disease , 2003, International Journal of Impotence Research.

[24]  M. Ferrini,et al.  Fibrin as an inducer of fibrosis in the tunica albuginea of the rat: a new animal model of Peyronie's disease , 2003, BJU international.

[25]  T. Shankey,et al.  Peyronie's disease cell culture models: phenotypic, genotypic and functional analyses , 2002, International Journal of Impotence Research.

[26]  J. Rajfer,et al.  Gene expression profiles in the Peyronie's disease plaque. , 2002, Urology.

[27]  D. Ralph,et al.  The Lue procedure: an analysis of the outcome in Peyronie's disease , 2002, BJU international.

[28]  T. H. Klotz,et al.  The prevalence of Peyronie's disease: results of a large survey , 2001, BJU international.

[29]  A Gefen,et al.  A biomechanical model of Peyronie's disease. , 2000, Journal of biomechanics.

[30]  W. Hellstrom,et al.  A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. , 2000, The Journal of urology.

[31]  R. Moreland Stimulation of collagen production in an in vitro model for Peyronie’s Disease , 2000, International Journal of Impotence Research.

[32]  T. Lue,et al.  Histological and ultrastructural alterations in an animal model of Peyronie's disease. , 1998, British journal of urology.

[33]  R. Dahiya,et al.  An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. , 1997, The Journal of urology.

[34]  A. Rearden,et al.  Peyronie's disease is associated with an HLA class II antigen, HLA-DQ5, implying an autoimmune etiology. , 1996, The Journal of urology.

[35]  L. Sandberg,et al.  Increased serum levels of anti-elastin antibodies in patients with Peyronie's disease. , 1994, The Journal of urology.

[36]  G. Mueller‐Eckhardt,et al.  HLA antigens in Peyronie's disease. , 1994, Urologia internationalis.

[37]  J. W. Mcroberts,et al.  Peyronie's disease. , 1969, Surgery, gynecology & obstetrics.